The global market for Fast-Acting Anesthetic was valued at US$ 2513 million in the year 2024 and is projected to reach a revised size of US$ 3433 million by 2031, growing at a CAGR of 4.6% during the forecast period.

Fast-Acting Anesthetic Market

A fast-acting anesthetic is a type of medication designed to quickly induce anesthesia or numbness, either locally or systemically, within a short period after administration. These anesthetics are used for rapid onset of action in procedures where immediate pain relief or sedation is required. They work by interfering with the nervous system's ability to transmit pain signals to the brain.

North American market for Fast-Acting Anesthetic is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Fast-Acting Anesthetic is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Fast-Acting Anesthetic include B. Braun, Hengrui, Humanwell Healthcare (Group), Pfizer, Sanofi, Maruishi, Nhwa-Group, Sinopharm Group, Piramal, Fresenius Kabi, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Fast-Acting Anesthetic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fast-Acting Anesthetic.

The Fast-Acting Anesthetic market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Fast-Acting Anesthetic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Fast-Acting Anesthetic manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Fast-Acting Anesthetic Market Report

Report Metric	Details
Report Name	Fast-Acting Anesthetic Market
Accounted market size in year	US$ 2513 million
Forecasted market size in 2031	US$ 3433 million
CAGR	4.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Injections Topical Oral Inhalants
Segment by Application	Hospital Clinic
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	B. Braun, Hengrui, Humanwell Healthcare (Group), Pfizer, Sanofi, Maruishi, Nhwa-Group, Sinopharm Group, Piramal, Fresenius Kabi, Aspen Pharmacare, Septodont, AstraZeneca, AbbVie, Baxter International, Hikma Pharmaceuticals, Hospira, Piramal Critical Care, Mylan
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Fast-Acting Anesthetic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Fast-Acting Anesthetic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Fast-Acting Anesthetic Market growing?

Ans: The Fast-Acting Anesthetic Market witnessing a CAGR of 4.6% during the forecast period 2025-2031.

What is the Fast-Acting Anesthetic Market size in 2031?

Ans: The Fast-Acting Anesthetic Market size in 2031 will be US$ 3433 million.

Who are the main players in the Fast-Acting Anesthetic Market report?

Ans: The main players in the Fast-Acting Anesthetic Market are B. Braun, Hengrui, Humanwell Healthcare (Group), Pfizer, Sanofi, Maruishi, Nhwa-Group, Sinopharm Group, Piramal, Fresenius Kabi, Aspen Pharmacare, Septodont, AstraZeneca, AbbVie, Baxter International, Hikma Pharmaceuticals, Hospira, Piramal Critical Care, Mylan

What are the Application segmentation covered in the Fast-Acting Anesthetic Market report?

Ans: The Applications covered in the Fast-Acting Anesthetic Market report are Hospital, Clinic

What are the Type segmentation covered in the Fast-Acting Anesthetic Market report?

Ans: The Types covered in the Fast-Acting Anesthetic Market report are Injections, Topical, Oral, Inhalants

1 Fast-Acting Anesthetic Market Overview

1.1 Product Definition

1.2 Fast-Acting Anesthetic by Type

1.2.1 Global Fast-Acting Anesthetic Market Value Comparison by Type (2024 VS 2031)

1.2.2 Injections

1.2.3 Topical

1.2.4 Oral

1.2.5 Inhalants

1.3 Fast-Acting Anesthetic by Application

1.3.1 Global Fast-Acting Anesthetic Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.4 Global Fast-Acting Anesthetic Market Size Estimates and Forecasts

1.4.1 Global Fast-Acting Anesthetic Revenue 2020-2031

1.4.2 Global Fast-Acting Anesthetic Sales 2020-2031

1.4.3 Global Fast-Acting Anesthetic Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Fast-Acting Anesthetic Market Competition by Manufacturers

2.1 Global Fast-Acting Anesthetic Sales Market Share by Manufacturers (2020-2025)

2.2 Global Fast-Acting Anesthetic Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Fast-Acting Anesthetic Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Fast-Acting Anesthetic, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Fast-Acting Anesthetic, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Fast-Acting Anesthetic, Product Type & Application

2.7 Global Key Manufacturers of Fast-Acting Anesthetic, Date of Enter into This Industry

2.8 Global Fast-Acting Anesthetic Market Competitive Situation and Trends

2.8.1 Global Fast-Acting Anesthetic Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Fast-Acting Anesthetic Players Market Share by Revenue

2.8.3 Global Fast-Acting Anesthetic Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Fast-Acting Anesthetic Market Scenario by Region

3.1 Global Fast-Acting Anesthetic Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Fast-Acting Anesthetic Sales by Region: 2020-2031

3.2.1 Global Fast-Acting Anesthetic Sales by Region: 2020-2025

3.2.2 Global Fast-Acting Anesthetic Sales by Region: 2026-2031

3.3 Global Fast-Acting Anesthetic Revenue by Region: 2020-2031

3.3.1 Global Fast-Acting Anesthetic Revenue by Region: 2020-2025

3.3.2 Global Fast-Acting Anesthetic Revenue by Region: 2026-2031

3.4 North America Fast-Acting Anesthetic Market Facts & Figures by Country

3.4.1 North America Fast-Acting Anesthetic Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Fast-Acting Anesthetic Sales by Country (2020-2031)

3.4.3 North America Fast-Acting Anesthetic Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Fast-Acting Anesthetic Market Facts & Figures by Country

3.5.1 Europe Fast-Acting Anesthetic Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Fast-Acting Anesthetic Sales by Country (2020-2031)

3.5.3 Europe Fast-Acting Anesthetic Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Fast-Acting Anesthetic Market Facts & Figures by Region

3.6.1 Asia Pacific Fast-Acting Anesthetic Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Fast-Acting Anesthetic Sales by Region (2020-2031)

3.6.3 Asia Pacific Fast-Acting Anesthetic Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Fast-Acting Anesthetic Market Facts & Figures by Country

3.7.1 Latin America Fast-Acting Anesthetic Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Fast-Acting Anesthetic Sales by Country (2020-2031)

3.7.3 Latin America Fast-Acting Anesthetic Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Fast-Acting Anesthetic Market Facts & Figures by Country

3.8.1 Middle East and Africa Fast-Acting Anesthetic Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Fast-Acting Anesthetic Sales by Country (2020-2031)

3.8.3 Middle East and Africa Fast-Acting Anesthetic Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Fast-Acting Anesthetic Sales by Type (2020-2031)

4.1.1 Global Fast-Acting Anesthetic Sales by Type (2020-2025)

4.1.2 Global Fast-Acting Anesthetic Sales by Type (2026-2031)

4.1.3 Global Fast-Acting Anesthetic Sales Market Share by Type (2020-2031)

4.2 Global Fast-Acting Anesthetic Revenue by Type (2020-2031)

4.2.1 Global Fast-Acting Anesthetic Revenue by Type (2020-2025)

4.2.2 Global Fast-Acting Anesthetic Revenue by Type (2026-2031)

4.2.3 Global Fast-Acting Anesthetic Revenue Market Share by Type (2020-2031)

4.3 Global Fast-Acting Anesthetic Price by Type (2020-2031)

5 Segment by Application

5.1 Global Fast-Acting Anesthetic Sales by Application (2020-2031)

5.1.1 Global Fast-Acting Anesthetic Sales by Application (2020-2025)

5.1.2 Global Fast-Acting Anesthetic Sales by Application (2026-2031)

5.1.3 Global Fast-Acting Anesthetic Sales Market Share by Application (2020-2031)

5.2 Global Fast-Acting Anesthetic Revenue by Application (2020-2031)

5.2.1 Global Fast-Acting Anesthetic Revenue by Application (2020-2025)

5.2.2 Global Fast-Acting Anesthetic Revenue by Application (2026-2031)

5.2.3 Global Fast-Acting Anesthetic Revenue Market Share by Application (2020-2031)

5.3 Global Fast-Acting Anesthetic Price by Application (2020-2031)

6 Key Companies Profiled

6.1 B. Braun

6.1.1 B. Braun Company Information

6.1.2 B. Braun Description and Business Overview

6.1.3 B. Braun Fast-Acting Anesthetic Sales, Revenue and Gross Margin (2020-2025)

6.1.4 B. Braun Fast-Acting Anesthetic Product Portfolio

6.1.5 B. Braun Recent Developments/Updates

6.2 Hengrui

6.2.1 Hengrui Company Information

6.2.2 Hengrui Description and Business Overview

6.2.3 Hengrui Fast-Acting Anesthetic Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Hengrui Fast-Acting Anesthetic Product Portfolio

6.2.5 Hengrui Recent Developments/Updates

6.3 Humanwell Healthcare (Group)

6.3.1 Humanwell Healthcare (Group) Company Information

6.3.2 Humanwell Healthcare (Group) Description and Business Overview

6.3.3 Humanwell Healthcare (Group) Fast-Acting Anesthetic Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Humanwell Healthcare (Group) Fast-Acting Anesthetic Product Portfolio

6.3.5 Humanwell Healthcare (Group) Recent Developments/Updates

6.4 Pfizer

6.4.1 Pfizer Company Information

6.4.2 Pfizer Description and Business Overview

6.4.3 Pfizer Fast-Acting Anesthetic Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Pfizer Fast-Acting Anesthetic Product Portfolio

6.4.5 Pfizer Recent Developments/Updates

6.5 Sanofi

6.5.1 Sanofi Company Information

6.5.2 Sanofi Description and Business Overview

6.5.3 Sanofi Fast-Acting Anesthetic Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Sanofi Fast-Acting Anesthetic Product Portfolio

6.5.5 Sanofi Recent Developments/Updates

6.6 Maruishi

6.6.1 Maruishi Company Information

6.6.2 Maruishi Description and Business Overview

6.6.3 Maruishi Fast-Acting Anesthetic Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Maruishi Fast-Acting Anesthetic Product Portfolio

6.6.5 Maruishi Recent Developments/Updates

6.7 Nhwa-Group

6.7.1 Nhwa-Group Company Information

6.7.2 Nhwa-Group Description and Business Overview

6.7.3 Nhwa-Group Fast-Acting Anesthetic Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Nhwa-Group Fast-Acting Anesthetic Product Portfolio

6.7.5 Nhwa-Group Recent Developments/Updates

6.8 Sinopharm Group

6.8.1 Sinopharm Group Company Information

6.8.2 Sinopharm Group Description and Business Overview

6.8.3 Sinopharm Group Fast-Acting Anesthetic Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Sinopharm Group Fast-Acting Anesthetic Product Portfolio

6.8.5 Sinopharm Group Recent Developments/Updates

6.9 Piramal

6.9.1 Piramal Company Information

6.9.2 Piramal Description and Business Overview

6.9.3 Piramal Fast-Acting Anesthetic Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Piramal Fast-Acting Anesthetic Product Portfolio

6.9.5 Piramal Recent Developments/Updates

6.10 Fresenius Kabi

6.10.1 Fresenius Kabi Company Information

6.10.2 Fresenius Kabi Description and Business Overview

6.10.3 Fresenius Kabi Fast-Acting Anesthetic Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Fresenius Kabi Fast-Acting Anesthetic Product Portfolio

6.10.5 Fresenius Kabi Recent Developments/Updates

6.11 Aspen Pharmacare

6.11.1 Aspen Pharmacare Company Information

6.11.2 Aspen Pharmacare Description and Business Overview

6.11.3 Aspen Pharmacare Fast-Acting Anesthetic Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Aspen Pharmacare Fast-Acting Anesthetic Product Portfolio

6.11.5 Aspen Pharmacare Recent Developments/Updates

6.12 Septodont

6.12.1 Septodont Company Information

6.12.2 Septodont Description and Business Overview

6.12.3 Septodont Fast-Acting Anesthetic Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Septodont Fast-Acting Anesthetic Product Portfolio

6.12.5 Septodont Recent Developments/Updates

6.13 AstraZeneca

6.13.1 AstraZeneca Company Information

6.13.2 AstraZeneca Description and Business Overview

6.13.3 AstraZeneca Fast-Acting Anesthetic Sales, Revenue and Gross Margin (2020-2025)

6.13.4 AstraZeneca Fast-Acting Anesthetic Product Portfolio

6.13.5 AstraZeneca Recent Developments/Updates

6.14 AbbVie

6.14.1 AbbVie Company Information

6.14.2 AbbVie Description and Business Overview

6.14.3 AbbVie Fast-Acting Anesthetic Sales, Revenue and Gross Margin (2020-2025)

6.14.4 AbbVie Fast-Acting Anesthetic Product Portfolio

6.14.5 AbbVie Recent Developments/Updates

6.15 Baxter International

6.15.1 Baxter International Company Information

6.15.2 Baxter International Description and Business Overview

6.15.3 Baxter International Fast-Acting Anesthetic Sales, Revenue and Gross Margin (2020-2025)

6.15.4 Baxter International Fast-Acting Anesthetic Product Portfolio

6.15.5 Baxter International Recent Developments/Updates

6.16 Hikma Pharmaceuticals

6.16.1 Hikma Pharmaceuticals Company Information

6.16.2 Hikma Pharmaceuticals Description and Business Overview

6.16.3 Hikma Pharmaceuticals Fast-Acting Anesthetic Sales, Revenue and Gross Margin (2020-2025)

6.16.4 Hikma Pharmaceuticals Fast-Acting Anesthetic Product Portfolio

6.16.5 Hikma Pharmaceuticals Recent Developments/Updates

6.17 Hospira

6.17.1 Hospira Company Information

6.17.2 Hospira Description and Business Overview

6.17.3 Hospira Fast-Acting Anesthetic Sales, Revenue and Gross Margin (2020-2025)

6.17.4 Hospira Fast-Acting Anesthetic Product Portfolio

6.17.5 Hospira Recent Developments/Updates

6.18 Piramal Critical Care

6.18.1 Piramal Critical Care Company Information

6.18.2 Piramal Critical Care Description and Business Overview

6.18.3 Piramal Critical Care Fast-Acting Anesthetic Sales, Revenue and Gross Margin (2020-2025)

6.18.4 Piramal Critical Care Fast-Acting Anesthetic Product Portfolio

6.18.5 Piramal Critical Care Recent Developments/Updates

6.19 Mylan

6.19.1 Mylan Company Information

6.19.2 Mylan Description and Business Overview

6.19.3 Mylan Fast-Acting Anesthetic Sales, Revenue and Gross Margin (2020-2025)

6.19.4 Mylan Fast-Acting Anesthetic Product Portfolio

6.19.5 Mylan Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Fast-Acting Anesthetic Industry Chain Analysis

7.2 Fast-Acting Anesthetic Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Fast-Acting Anesthetic Production Mode & Process Analysis

7.4 Fast-Acting Anesthetic Sales and Marketing

7.4.1 Fast-Acting Anesthetic Sales Channels

7.4.2 Fast-Acting Anesthetic Distributors

7.5 Fast-Acting Anesthetic Customer Analysis

8 Fast-Acting Anesthetic Market Dynamics

8.1 Fast-Acting Anesthetic Industry Trends

8.2 Fast-Acting Anesthetic Market Drivers

8.3 Fast-Acting Anesthetic Market Challenges

8.4 Fast-Acting Anesthetic Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Hikma Pharmaceuticals

Hospira

Piramal Critical Care

Mylan NV

Humanwell Healthcare (Group)

List of Tables

Table 1. Global Fast-Acting Anesthetic Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Fast-Acting Anesthetic Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Fast-Acting Anesthetic Market Competitive Situation by Manufacturers in 2024

Table 4. Global Fast-Acting Anesthetic Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Fast-Acting Anesthetic Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Fast-Acting Anesthetic Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Fast-Acting Anesthetic Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Fast-Acting Anesthetic Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Fast-Acting Anesthetic, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Fast-Acting Anesthetic, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Fast-Acting Anesthetic, Product Type & Application

Table 12. Global Key Manufacturers of Fast-Acting Anesthetic, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Fast-Acting Anesthetic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fast-Acting Anesthetic as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Fast-Acting Anesthetic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Fast-Acting Anesthetic Sales by Region (2020-2025) & (K Units)

Table 18. Global Fast-Acting Anesthetic Sales Market Share by Region (2020-2025)

Table 19. Global Fast-Acting Anesthetic Sales by Region (2026-2031) & (K Units)

Table 20. Global Fast-Acting Anesthetic Sales Market Share by Region (2026-2031)

Table 21. Global Fast-Acting Anesthetic Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Fast-Acting Anesthetic Revenue Market Share by Region (2020-2025)

Table 23. Global Fast-Acting Anesthetic Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Fast-Acting Anesthetic Revenue Market Share by Region (2026-2031)

Table 25. North America Fast-Acting Anesthetic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Fast-Acting Anesthetic Sales by Country (2020-2025) & (K Units)

Table 27. North America Fast-Acting Anesthetic Sales by Country (2026-2031) & (K Units)

Table 28. North America Fast-Acting Anesthetic Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Fast-Acting Anesthetic Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Fast-Acting Anesthetic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Fast-Acting Anesthetic Sales by Country (2020-2025) & (K Units)

Table 32. Europe Fast-Acting Anesthetic Sales by Country (2026-2031) & (K Units)

Table 33. Europe Fast-Acting Anesthetic Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Fast-Acting Anesthetic Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Fast-Acting Anesthetic Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Fast-Acting Anesthetic Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Fast-Acting Anesthetic Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Fast-Acting Anesthetic Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Fast-Acting Anesthetic Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Fast-Acting Anesthetic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Fast-Acting Anesthetic Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Fast-Acting Anesthetic Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Fast-Acting Anesthetic Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Fast-Acting Anesthetic Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Fast-Acting Anesthetic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Fast-Acting Anesthetic Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Fast-Acting Anesthetic Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Fast-Acting Anesthetic Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Fast-Acting Anesthetic Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Fast-Acting Anesthetic Sales (K Units) by Type (2020-2025)

Table 51. Global Fast-Acting Anesthetic Sales (K Units) by Type (2026-2031)

Table 52. Global Fast-Acting Anesthetic Sales Market Share by Type (2020-2025)

Table 53. Global Fast-Acting Anesthetic Sales Market Share by Type (2026-2031)

Table 54. Global Fast-Acting Anesthetic Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Fast-Acting Anesthetic Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Fast-Acting Anesthetic Revenue Market Share by Type (2020-2025)

Table 57. Global Fast-Acting Anesthetic Revenue Market Share by Type (2026-2031)

Table 58. Global Fast-Acting Anesthetic Price (US$/Unit) by Type (2020-2025)

Table 59. Global Fast-Acting Anesthetic Price (US$/Unit) by Type (2026-2031)

Table 60. Global Fast-Acting Anesthetic Sales (K Units) by Application (2020-2025)

Table 61. Global Fast-Acting Anesthetic Sales (K Units) by Application (2026-2031)

Table 62. Global Fast-Acting Anesthetic Sales Market Share by Application (2020-2025)

Table 63. Global Fast-Acting Anesthetic Sales Market Share by Application (2026-2031)

Table 64. Global Fast-Acting Anesthetic Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Fast-Acting Anesthetic Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Fast-Acting Anesthetic Revenue Market Share by Application (2020-2025)

Table 67. Global Fast-Acting Anesthetic Revenue Market Share by Application (2026-2031)

Table 68. Global Fast-Acting Anesthetic Price (US$/Unit) by Application (2020-2025)

Table 69. Global Fast-Acting Anesthetic Price (US$/Unit) by Application (2026-2031)

Table 70. B. Braun Company Information

Table 71. B. Braun Description and Business Overview

Table 72. B. Braun Fast-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. B. Braun Fast-Acting Anesthetic Product

Table 74. B. Braun Recent Developments/Updates

Table 75. Hengrui Company Information

Table 76. Hengrui Description and Business Overview

Table 77. Hengrui Fast-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Hengrui Fast-Acting Anesthetic Product

Table 79. Hengrui Recent Developments/Updates

Table 80. Humanwell Healthcare (Group) Company Information

Table 81. Humanwell Healthcare (Group) Description and Business Overview

Table 82. Humanwell Healthcare (Group) Fast-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Humanwell Healthcare (Group) Fast-Acting Anesthetic Product

Table 84. Humanwell Healthcare (Group) Recent Developments/Updates

Table 85. Pfizer Company Information

Table 86. Pfizer Description and Business Overview

Table 87. Pfizer Fast-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Pfizer Fast-Acting Anesthetic Product

Table 89. Pfizer Recent Developments/Updates

Table 90. Sanofi Company Information

Table 91. Sanofi Description and Business Overview

Table 92. Sanofi Fast-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Sanofi Fast-Acting Anesthetic Product

Table 94. Sanofi Recent Developments/Updates

Table 95. Maruishi Company Information

Table 96. Maruishi Description and Business Overview

Table 97. Maruishi Fast-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Maruishi Fast-Acting Anesthetic Product

Table 99. Maruishi Recent Developments/Updates

Table 100. Nhwa-Group Company Information

Table 101. Nhwa-Group Description and Business Overview

Table 102. Nhwa-Group Fast-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Nhwa-Group Fast-Acting Anesthetic Product

Table 104. Nhwa-Group Recent Developments/Updates

Table 105. Sinopharm Group Company Information

Table 106. Sinopharm Group Description and Business Overview

Table 107. Sinopharm Group Fast-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Sinopharm Group Fast-Acting Anesthetic Product

Table 109. Sinopharm Group Recent Developments/Updates

Table 110. Piramal Company Information

Table 111. Piramal Description and Business Overview

Table 112. Piramal Fast-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Piramal Fast-Acting Anesthetic Product

Table 114. Piramal Recent Developments/Updates

Table 115. Fresenius Kabi Company Information

Table 116. Fresenius Kabi Description and Business Overview

Table 117. Fresenius Kabi Fast-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Fresenius Kabi Fast-Acting Anesthetic Product

Table 119. Fresenius Kabi Recent Developments/Updates

Table 120. Aspen Pharmacare Company Information

Table 121. Aspen Pharmacare Description and Business Overview

Table 122. Aspen Pharmacare Fast-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Aspen Pharmacare Fast-Acting Anesthetic Product

Table 124. Aspen Pharmacare Recent Developments/Updates

Table 125. Septodont Company Information

Table 126. Septodont Description and Business Overview

Table 127. Septodont Fast-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. Septodont Fast-Acting Anesthetic Product

Table 129. Septodont Recent Developments/Updates

Table 130. AstraZeneca Company Information

Table 131. AstraZeneca Description and Business Overview

Table 132. AstraZeneca Fast-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 133. AstraZeneca Fast-Acting Anesthetic Product

Table 134. AstraZeneca Recent Developments/Updates

Table 135. AbbVie Company Information

Table 136. AbbVie Description and Business Overview

Table 137. AbbVie Fast-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 138. AbbVie Fast-Acting Anesthetic Product

Table 139. AbbVie Recent Developments/Updates

Table 140. Baxter International Company Information

Table 141. Baxter International Description and Business Overview

Table 142. Baxter International Fast-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 143. Baxter International Fast-Acting Anesthetic Product

Table 144. Baxter International Recent Developments/Updates

Table 145. Hikma Pharmaceuticals Company Information

Table 146. Hikma Pharmaceuticals Description and Business Overview

Table 147. Hikma Pharmaceuticals Fast-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 148. Hikma Pharmaceuticals Fast-Acting Anesthetic Product

Table 149. Hikma Pharmaceuticals Recent Developments/Updates

Table 150. Hospira Company Information

Table 151. Hospira Description and Business Overview

Table 152. Hospira Fast-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 153. Hospira Fast-Acting Anesthetic Product

Table 154. Hospira Recent Developments/Updates

Table 155. Piramal Critical Care Company Information

Table 156. Piramal Critical Care Description and Business Overview

Table 157. Piramal Critical Care Fast-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 158. Piramal Critical Care Fast-Acting Anesthetic Product

Table 159. Piramal Critical Care Recent Developments/Updates

Table 160. Mylan Company Information

Table 161. Mylan Description and Business Overview

Table 162. Mylan Fast-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 163. Mylan Fast-Acting Anesthetic Product

Table 164. Mylan Recent Developments/Updates

Table 165. Key Raw Materials Lists

Table 166. Raw Materials Key Suppliers Lists

Table 167. Fast-Acting Anesthetic Distributors List

Table 168. Fast-Acting Anesthetic Customers List

Table 169. Fast-Acting Anesthetic Market Trends

Table 170. Fast-Acting Anesthetic Market Drivers

Table 171. Fast-Acting Anesthetic Market Challenges

Table 172. Fast-Acting Anesthetic Market Restraints

Table 173. Research Programs/Design for This Report

Table 174. Key Data Information from Secondary Sources

Table 175. Key Data Information from Primary Sources

Table 176. Authors List of This Report

List of Figures

Figure 1. Product Picture of Fast-Acting Anesthetic

Figure 2. Global Fast-Acting Anesthetic Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Fast-Acting Anesthetic Market Share by Type: 2024 & 2031

Figure 4. Injections Product Picture

Figure 5. Topical Product Picture

Figure 6. Oral Product Picture

Figure 7. Inhalants Product Picture

Figure 8. Global Fast-Acting Anesthetic Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Fast-Acting Anesthetic Market Share by Application: 2024 & 2031

Figure 10. Hospital

Figure 11. Clinic

Figure 12. Global Fast-Acting Anesthetic Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Fast-Acting Anesthetic Market Size (2020-2031) & (US$ Million)

Figure 14. Global Fast-Acting Anesthetic Sales (2020-2031) & (K Units)

Figure 15. Global Fast-Acting Anesthetic Average Price (US$/Unit) & (2020-2031)

Figure 16. Fast-Acting Anesthetic Report Years Considered

Figure 17. Fast-Acting Anesthetic Sales Share by Manufacturers in 2024

Figure 18. Global Fast-Acting Anesthetic Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Fast-Acting Anesthetic Players: Market Share by Revenue in Fast-Acting Anesthetic in 2024

Figure 20. Fast-Acting Anesthetic Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Fast-Acting Anesthetic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Fast-Acting Anesthetic Sales Market Share by Country (2020-2031)

Figure 23. North America Fast-Acting Anesthetic Revenue Market Share by Country (2020-2031)

Figure 24. United States Fast-Acting Anesthetic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Fast-Acting Anesthetic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Fast-Acting Anesthetic Sales Market Share by Country (2020-2031)

Figure 27. Europe Fast-Acting Anesthetic Revenue Market Share by Country (2020-2031)

Figure 28. Germany Fast-Acting Anesthetic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Fast-Acting Anesthetic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Fast-Acting Anesthetic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Fast-Acting Anesthetic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Fast-Acting Anesthetic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Fast-Acting Anesthetic Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Fast-Acting Anesthetic Revenue Market Share by Region (2020-2031)

Figure 35. China Fast-Acting Anesthetic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Fast-Acting Anesthetic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Fast-Acting Anesthetic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Fast-Acting Anesthetic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Fast-Acting Anesthetic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Fast-Acting Anesthetic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Fast-Acting Anesthetic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Latin America Fast-Acting Anesthetic Sales Market Share by Country (2020-2031)

Figure 43. Latin America Fast-Acting Anesthetic Revenue Market Share by Country (2020-2031)

Figure 44. Mexico Fast-Acting Anesthetic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Brazil Fast-Acting Anesthetic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Argentina Fast-Acting Anesthetic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Colombia Fast-Acting Anesthetic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Fast-Acting Anesthetic Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Fast-Acting Anesthetic Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Fast-Acting Anesthetic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Fast-Acting Anesthetic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Fast-Acting Anesthetic Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Fast-Acting Anesthetic by Type (2020-2031)

Figure 54. Global Revenue Market Share of Fast-Acting Anesthetic by Type (2020-2031)

Figure 55. Global Fast-Acting Anesthetic Price (US$/Unit) by Type (2020-2031)

Figure 56. Global Sales Market Share of Fast-Acting Anesthetic by Application (2020-2031)

Figure 57. Global Revenue Market Share of Fast-Acting Anesthetic by Application (2020-2031)

Figure 58. Global Fast-Acting Anesthetic Price (US$/Unit) by Application (2020-2031)

Figure 59. Fast-Acting Anesthetic Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions